Additionally, genetic or pharmacological disruption of CPT1A shuts down NADPH supply, thereby preventing anchorage-independent growth of ESCC cells in vitro and lung metastasis in xenograft tumor models (50). Here, CPT1A is linked to esophageal squamous cell carcinoma.